Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Cholecystokinin is a brain/gut peptide. Additionally we are shipping Cholecystokinin Kits (65) and Cholecystokinin Proteins (20) and many more products for this protein.
Showing 10 out of 76 products:
Cow (Bovine) Polyclonal Cholecystokinin Primary Antibody for WB - ABIN2778154
Roskos, Wallace, Weiss: Readability of consumer medication information for intranasal corticosteroid inhalers. in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007
Show all 3 references for ABIN2778154
Cat (Feline) Polyclonal Cholecystokinin Primary Antibody for IHC (fro), IF - ABIN113497
Lönroth, Håkanson, Lundell, Sundler: Histamine containing endocrine cells in the human stomach. in Gut 1990
The CCK polymorphism have reported significant association of -45C>T polymorphism with the presence of hallucinations.
CCK does not appear to play a unique independent role in satiety/satiation.
CCK release has been found to be halved in pregnant women with hyperemesis gravidarium, which supports the hypothesis that gastrointestinal motility is increased in pregnant women with hyperemesis gravidarium.
CCK in plasma is an independent marker of cardiovascular mortality in elderly female patients.
These data offer preliminary evidence supporting an association between the rs1799923 polymorphism in the CCK gene and PTSD
Data suggest that endocrine responses differ between jejunal and gastric enteral feeding, with higher peak plasma CCK (cholecystokinin), PYY (peptide YY), and GLP-1/2 (glucagon-like peptides 1/2) concentrations being attained after jejunal feeding.
active GLP-1 (show GCG Antibodies) produced in the islet stimulates cholecystokinin production and secretion in a paracrine manner via cyclic AMP (show APRT Antibodies) and CREB (show CREB1 Antibodies).
Cardiac expression of pro-cholecystokinin is cell-specific, which differentiates the expression from that of intestinal endocrine cells and cerebral neurons. Plasma Pro-CCK is a prognostic marker in patients with stable heart failure.
CCK binding modulates the contractile function of the lower esophageal sphincter through differential binding to the CCK-A receptor (show CCKAR Antibodies) on the sling and clasp (show CLASRP Antibodies) fibers
Data suggest that up-regulation of plasma CCK levels is 50% higher following breakfast of meal replacement beverage containing fat emulsion of rapeseed oil with droplet size of 0.1 um (versus 0.3 um); satiety response and food intake are unaffected.
These studies reemphasize the beneficial effects imparted by co-administration of obestatin and CCK8 and their potential use towards countering obesity.
that Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia
new information on the cell specific localization of NUCB2/nesfatin-1 (show NUCB2 Antibodies) in the intestinal mucosa, and a novel function for nesfatin-1 (show NUCB2 Antibodies) in modulating intestinal CCK and PYY expression and secretion
Results showed that CCK is important for lipid transport and energy expenditure to control body weight in response to dietary lipid feeding
SP1 (show SP1 Antibodies) results in a CCK response deficiency that may contribute to the increased meal size and overall hyperphagia in synphillin-1 transgenic mice
serves as a novel positive modulator of ventricular remodelling after myocardial infarction via the regulation of NF-kappaB (show NFKB1 Antibodies) and p38 (show CRK Antibodies) signalling
active GLP-1 (show GCG Antibodies) produced in the islet stimulates cholecystokinin production and secretion in a paracrine manner via cyclic AMP (show TMPRSS5 Antibodies) and CREB (show CREB1 Antibodies).
Data (including data from studies using transgenic mice) suggest that enhanced Cck expression in pancreatic beta-cells protects these cells from the cell-withering effects of aging, apoptotic stress, and (streptozotocin-induced) diabetes type 2.
Deoxynivalenol induced cholecystokinin and glucagon-like peptide 1 (show GCG Antibodies) release by enteroendocrine cells in mediated by casR (show CASR Antibodies)/TRPA1 (show TRPA1 Antibodies) signaling.
Bacterial polysaccharide-responsive miR (show MLXIP Antibodies)-150 and miR (show MLXIP Antibodies)-143 RIPK2 (show RIPK2 Antibodies) and TAK1 (show NR2C2 Antibodies) to suppress NOD2 (show NOD2 Antibodies)-induced immunomodulators.
Cardiac expression of pro-cholecystokinin is cell-specific, which differentiates the expression from that of intestinal endocrine cells and cerebral neurons.
This review explores the role of luminal cholecystokinin on the regulation of exocrine pancreatic secretion in author's studies of neonatal pigs.
This review explores the role of luminal cholecystokinin on the regulation of exocrine pancreatic secretion in author's studies of newborn calves.
Cholecystokinin is a brain/gut peptide. In the gut, it induces the release of pancreatic enzymes and the contraction of the gallbladder. In the brain, its physiologic role is unclear. The cholecystokinin pro-hormone is processed by endo- and exo-proteolytic cleavages. Two transcript variants encoding the same protein have been found for this gene.
, cholecystokinin triacontatriapeptide
, receptor-interacting serine/threonine-protein kinase 2
, tyrosine-protein kinase RIPK2